441 related articles for article (PubMed ID: 37047633)
1. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.
Teschke R
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047633
[TBL] [Abstract][Full Text] [Related]
2. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.
Teschke R; Uetrecht J
Ann Transl Med; 2021 Apr; 9(8):730. PubMed ID: 33987428
[TBL] [Abstract][Full Text] [Related]
4. Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method.
Teschke R; Danan G
Medicines (Basel); 2024 Apr; 11(4):. PubMed ID: 38667507
[TBL] [Abstract][Full Text] [Related]
5. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
Teschke R; Danan G
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
[TBL] [Abstract][Full Text] [Related]
6. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
Teschke R; Schulze J; Eickhoff A; Danan G
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
[TBL] [Abstract][Full Text] [Related]
7. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.
Teschke R
Front Pharmacol; 2019; 10():730. PubMed ID: 31396080
[TBL] [Abstract][Full Text] [Related]
8. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
9. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
Teschke R; Danan G
Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
[No Abstract] [Full Text] [Related]
10. Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies.
Teschke R; Danan G
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810530
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Drug-Induced Liver Injury.
Teschke R
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672522
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
Devarbhavi H; Raj S; Aradya VH; Rangegowda VT; Veeranna GP; Singh R; Reddy V; Patil M
Hepatology; 2016 Mar; 63(3):993-9. PubMed ID: 26439084
[TBL] [Abstract][Full Text] [Related]
13. An Update on Drug-induced Liver Injury.
Devarbhavi H
J Clin Exp Hepatol; 2012 Sep; 2(3):247-59. PubMed ID: 25755441
[TBL] [Abstract][Full Text] [Related]
14. RUCAM in Drug and Herb Induced Liver Injury: The Update.
Danan G; Teschke R
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712744
[TBL] [Abstract][Full Text] [Related]
15. Warfarin-induced Stevens-Johnson syndrome with severe liver injury.
Xiong H; Liu T; Xiao J; Wan J; Yang J; Huang G; Han Y; Liu G; Dong X
J Int Med Res; 2021 Jul; 49(7):3000605211033196. PubMed ID: 34311601
[TBL] [Abstract][Full Text] [Related]
16. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
17. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
Teschke R; Eickhoff A; Schulze J; Danan G
Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
[TBL] [Abstract][Full Text] [Related]
18. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
[No Abstract] [Full Text] [Related]
19. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future.
Danan G; Teschke R
Front Pharmacol; 2019; 10():853. PubMed ID: 31417407
[TBL] [Abstract][Full Text] [Related]
20. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method.
Ye L; Feng Z; Huang L; Guo C; Wu X; He L; Tan W; Wang Y; Wu X; Hu B; Li T; Yang G; Chengxian G; He Q
Front Pharmacol; 2021; 12():790108. PubMed ID: 34987403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
